2m 2m 2m 2m 2m 2m 2m
Enlivex (ENLV)
NASDAQ
$0.63+$0.009 (+1.44%)
Price as of Jun 23, 2026 7:51 PM EDT- $147.9MMarket Cap
- -46.29%1-Year Change
- BiotechnologyIndustry
Enlivex (ENLV)
$0.63+$0.009 (+1.44%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 363.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 363.2M N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -9.2M -13.36% | -10.6M -44.12% | -19.0M +1.71% | -18.7M +45.12% | |
Depreciation and Amortization Expense | 332,000 -39.08% | 545,000 -34.73% | 835,000 +7.46% | 777,000 +42.31% | |
Total Operating Expenses | 15.0M -5.41% | 15.9M -45.95% | 29.4M +13.95% | 25.8M +33.75% | |
Operating Profit | -15.0M -5.41% | -15.9M -45.95% | -29.4M +13.95% | -25.8M +33.75% | |
Interest Income | 792,000 -25.91% | 1.1M -31.69% | 1.6M +87.43% | 835,000 +595.83% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 792,000 -25.91% | 1.1M -31.69% | 1.6M +87.43% | 835,000 +595.83% | |
Total Nonoperating Income and Expense | 1.9M +120.59% | 874,000 +167.28% | 327,000 +106.21% | -5.3M -209.19% | |
Income before Taxes | 1.6B +10,284.88% | -15.9M -45.95% | -29.4M +13.95% | -25.8M +33.75% | |
Income Taxes | 382.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 1.2B +8,329.17% | -15.0M -48.35% | -29.1M -6.41% | -31.1M +114.68% | |
Net Income from Continuing Operations Applicable to Common | 1.6B +10,877.77% | -15.0M -48.35% | -29.1M -6.41% | -31.1M +114.68% | |
Basic EPS and Net Income | 27.04 +3,804.11% | -0.73 -53.21% | -1.56 -7.69% | -1.69 N/A | |
Diluted EPS and Net Income | 25.48 +3,590.41% | -0.73 -53.21% | -1.56 -7.69% | -1.69 N/A | |
Basic Weighted Average Shares | 45.7M +122.76% | 20.5M +10.44% | 18.6M N/A | N/A N/A | |
Diluted Weighted Average Shares | 48.5M +136.42% | 20.5M +10.44% | 18.6M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.9M -42.62% | 3.3M +306.03% | 813,000 -98.37% | 49.9M +345.86% | |
Short-Term Investments | N/A N/A | 198,000 -96.12% | 5.1M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.9M -45.87% | 3.5M -40.91% | 5.9M -88.14% | 49.9M -32.62% | |
Total Current Assets | 1.7B +6,606.34% | 26.0M -23.02% | 33.8M -35.48% | 52.3M -39.46% | |
Accumulated Depreciation | 2.1M +4.22% | 2.0M -31.39% | 2.9M +36.21% | 2.1M +58.42% | |
Property and Plant and Equipment and Net | 361,000 -42.24% | 625,000 -59.39% | 1.5M -84.42% | 9.9M +290.32% | |
Total Long-Term Assets | 583.8M +34,363.99% | 1.7M -44.77% | 3.1M -79.97% | 15.3M +75.92% | |
Total Assets | 2.3B +8,304.66% | 27.7M -24.83% | 36.8M -45.55% | 67.6M -28.91% | |
Income Taxes Payable | 382.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 9.0M +137.46% | 3.8M -37.32% | 6.1M -8.26% | 6.6M +40.04% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 4.2M -22.17% | |
Total Long-Term Liabilities | 383.0M +128,003.34% | 299,000 -56.41% | 686,000 -83.64% | 4.2M -22.17% | |
Total Liabilities | 392.1M +9,466.86% | 4.1M -39.26% | 6.7M -37.53% | 10.8M +6.87% | |
Retained Earnings | 1.1B +972.04% | -127.1M +13.39% | -112.1M +35.01% | -83.0M +59.77% | |
Total Stockholders Equity | 1.9B +8,102.76% | 23.6M -21.59% | 30.1M -47.07% | 56.8M -33.16% | |
Total Shares Outstanding | 237.4M +903.69% | 23.7M +27.17% | 18.6M +0.96% | 18.4M +0.49% | |
Cash Flow | |||||
Cash from Operating Activities | -10.4M -19.93% | -13.0M -44.70% | -23.5M -1.80% | -24.0M +36.55% | |
Capital Expenditures | 68,000 -33.98% | 103,000 -56.36% | 236,000 -97.09% | 8.1M +399.82% | |
Cash from Investing Activities | -1.3M -114.60% | 9.1M +134.89% | -26.0M -141.53% | 62.5M +262.79% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.4M +60.85% | 6.5M +1,692.78% | 360,000 +140.00% | 150,000 -99.75% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -4.14% N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | 104.94% +325.48% | -46.54% -16.36% | -55.65% +45.82% | -38.16% +78.70% | |
Return on Equity | 126.17% +325.52% | -55.95% -16.35% | -66.88% +52.75% | -43.78% +82.37% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 193.24 +2,724.21% | 6.84 +22.82% | 5.57 -29.67% | 7.92 -56.77% | |
Cash Ratio | 0.21 -75.83% | 0.87 +547.95% | 0.13 -98.23% | 7.56 +218.38% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow